Fig. 1
From: STAT1 and m6A-mediated IL15RA upregulation promotes metastasis via ZEB1/NF-κΒ axis in ccRCC
IL15RA acts as a promising clinical biomarker for cancers. (A). The correlation between IL15RA expression and IL15, IL2, IL2RA, IL2RG. (B). Paired expression of IL15RA in 33 types of tumors. (C). Univariate Cox analysis of IL15RA and OS, DSS, DFI, PFI at pan-cancer level. (D). Kaplan-Meier analysis of the relationship between IL15RA expression and survival features of tumors in TCGA database, OS Survival Map. (E). OS KMplot analysis of BRCA, KIRP, LAML, LIHC, MESO, PAAD, SKCM, UVM. (F). RFS Survival Map. (G). Diagnosis analysis of IL15RA.ROC analysis of the relationship between IL15RA and clinical diagnosis of tumors in TCGA. IL15RA can better predict cancer diagnosis in KICH, KIRC, CHOL, HNSC, GBM, READ, STAD, and UCEC. (H). Analysis of the expression difference of the IL15RA gene in samples of different clinical stages in each tumor. (I). Analysis of the expression difference of the IL15RA gene in samples of different clinical grades in each tumor. (J). Analysis of the expression difference of the IL15RA gene in samples of different clinical T stages in each tumor. (K). Analysis of the expression difference of the IL15RA gene in samples of different clinical N stages in each tumor. (L). Analysis of the expression difference of the IL15RA gene in samples of different clinical M stages in each tumor. *P < 0.05; **P < 0.01; ***P < 0.001; ****P < 0.0001.
